Ask the Expert: Optimal Treatment for ER+, HER2− Early-Stage Breast Cancer in Males
Optimal Treatment for ER+, HER2− Early-Stage Breast Cancer in Males
Clifford Hudis, MD
20120030
2012 Jan 30
Ask the Expert: Optimal Treatment for ER+, HER2− Early-Stage Breast Cancer in Males
2012 Jan 30, Clifford Hudis, MD
"Ask the Expert” features answers by our experts to your clinical questions. Question: What is the current hormonal therapy recommendation for male breast cancer patients who are ER+, PR+, HER2−, and stage I with no lymph node involvement?Answer: This is an adjuvant therapy question, and the short answer is that we typically treat men in the same way we treat postmenopausal women, but we lean towards tamoxifen, where there is a longer track record in terms of experience.